Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-331

  1. 1,098 Posts.
    lightbulb Created with Sketch. 172
    I think there is an error in your calculation. 40 total patients with an average reduction of 14%, not 2 %.
    I won't read too much into the supposedly 'failure' of this trial due to a number of factors
    - small sample size
    - the trial is of very short duration- 6 months or so, the landmark trial for irbersartan (
    . 2001 Sep 20;345(12):870-8.
    doi: 10.1056/NEJMoa011489.)
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
0.005(1.20%)
Mkt cap ! $234.8M
Open High Low Value Volume
40.5¢ 42.5¢ 39.5¢ $275.3K 673.4K

Buyers (Bids)

No. Vol. Price($)
9 8525 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 13660 7
View Market Depth
Last trade - 13.41pm 04/04/2025 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.